Tens of thousands of lawsuits have been filed against the company claiming its talcum powder products caused health issues.
A subsidiary of Johnson & Johnson is now proposing to pay approximately $6.48 billion over 25 years as part of a settlement in the U.S. to cover allegations that its baby powder containing talc caused ovarian cancer.
The claims contributed to drop in J&J's sales of baby powder, prompting the company to stop selling its talc-based products in 2020. In 2022, J&J announced plans to cease sales of the product worldwide. J&J said that the plan would resolve 99.75% of all pending talc lawsuits against it and its affiliates in the U.S.Johnson & Johnson Loses More Ground In Talc-Powder Cancer Case Katie Link 4:28 PM, May 03, 2016 The remaining pending personal injury lawsuits that relate to mesothelioma will be addressed outside of the plan. The company said that it has already resolved 95% of mesothelioma lawsuits filed to date.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Coaches Corner: A Q&A with Johnson boys soccer coach David JohnsonIn this Q&A, Johnson boys soccer coach David Johnson discusses the Jaguars’ upcoming playoff game against Austin Westlake.
Weiterlesen »
Johnson & Johnson to Acquire Shockwave Medical for $13 BillionJohnson & Johnson is investing $13 billion in Shockwave Medical, a company specializing in technology for opening clogged arteries. The deal involves cash acquisition and will help expand heart care services. Shockwave uses intravascular lithotripsy technology to crack calcium lesions in arteries and restore blood flow.
Weiterlesen »
Johnson & Johnson to Acquire Shockwave Medical in $13 Billion DealJohnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
Weiterlesen »
Johnson & Johnson to Acquire Shockwave Medical in $13 Billion DealJohnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.
Weiterlesen »
Johnson & Johnson to Acquire Shockwave Medical for $13.1 BillionJohnson & Johnson is purchasing Shockwave Medical for $13.1 billion to enhance its heart care capabilities. The deal is set to be completed by mid-year.
Weiterlesen »
Aaron Taylor-Johnson and Sam Taylor-Johnson Relationship TimelineGina Vivinetto is a writer for TODAY.com.
Weiterlesen »